slide 1 of 1


How leading-edge R&D teams are using RWE




nicolle gatto

Nicolle Gatto, Ph.D., M.P.H.

Senior Vice President, Scientific Research, Aetion

Julie Schiffman

Julie Schiffman

Senior Vice President, Scientific Engagement and Delivery, Aetion

Bob LoCasale

Bob LoCasale, Ph.D.

Head of RWE, Sanofi

Najat Khan

Najat Khan, Ph.D.

Chief Data Science Officer, Janssen R&D

What you'll learn


Updates on the state of RWE in 2021, including trends in regulatory approvals and anticipated guidances this year.


Examples of how biopharma can use RWE to inform trial feasibility and design, to test lab-developed hypotheses, and to support label expansion.


How global biopharma companies are integrating RWE across their R&D teams, with insight into trends and best practices for operationalizing adoption.


Watch Now

View the webinar to learn how RWE can accelerate drug development.